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Decreases in self-reported alcohol consumption
following HIV counseling and testing at Mulago
Hospital, Kampala, Uganda
Judith A Hahn1*, Robin Fatch1, Rhoda K Wanyenze2, Steven Baveewo3, Moses R Kamya2, David R Bangsberg4
and Thomas J Coates5

Abstract
Background: Alcohol use has a detrimental impact on the HIV epidemic, especially in sub-Saharan Africa. HIV
counseling and testing (HCT) may provide a contact opportunity to intervene with hazardous alcohol use; however,
little is known about how alcohol consumption changes following HCT.
Methods: We utilized data from 2056 participants of a randomized controlled trial comparing two methods of HCT
and subsequent linkage to HIV care conducted at Mulago Hospital in Kampala, Uganda. Those who had not
previously tested positive for HIV and whose last HIV test was at least one year in the past were eligible. Participants
were asked at baseline when they last consumed alcohol, and prior three month alcohol consumption was
measured using the Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) at baseline and quarterly
for one year. Hazardous alcohol consumption was defined as scoring ≥3 or ≥4 for women and men, respectively.
We examined correlates of alcohol use at baseline, and of hazardous and non-hazardous drinking during the year
of follow-up using multinomial logistic regression, clustered at the participant level to account for repeated
measurements.
Results: Prior to HCT, 30% were current drinkers (prior three months), 27% were past drinkers (>3 months ago), and
44% were lifetime abstainers. One-third (35%) of the current drinkers met criteria for hazardous drinking. Hazardous
and non-hazardous self-reported alcohol consumption declined after HCT, with 16% of baseline current drinkers
reporting hazardous alcohol use 3 months after HCT. Independent predictors (p < 0.05) of continuing non-hazardous
and hazardous alcohol consumption after HCT were sex (male), alcohol consumption prior to HCT (hazardous), and HIV
status (negative). Among those with HIV, non-hazardous drinking was less likely among those taking antiretroviral
therapy (ART).
Conclusions: HCT may be an opportune time to intervene with alcohol consumption. Those with HIV experienced
greater declines in alcohol consumption after HCT, and non-hazardous drinking decreased for those with HIV initiating
ART. HCT and ART initiation may be ideal times to intervene with alcohol consumption. Screening and brief intervention
(SBI) to reduce alcohol consumption should be considered for HCT and HIV treatment venues.
Keywords: Alcohol, Africa, HIV, HIV counseling and testing, Antiretroviral therapy, Screening and brief intervention
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Background
Heavy alcohol consumption is known to have detrimental effects on health, accounting for approximately 4.5%
of the global burden of disease and injury world-wide
[1]. Heavy alcohol use is a common and growing problem in sub-Saharan Africa (SSA). In Uganda, heavy alcohol consumption among drinkers is especially common
[1]. Among male drinkers, the per capita yearly pure alcohol consumption is 25.6 liters; among female drinkers,
the per capita yearly pure alcohol consumption is 19.6
liters [1].
Sub-Saharan Africa is home to nearly 70% of the global HIV infections (UNAIDS report 2011), and the heavy
alcohol consumption in this region exacerbates the
problem for multiple reasons [2]. First, alcohol consumption and drinking venue attendance in SSA have
been associated with increased HIV risk behaviors, such
as number of sexual partners, unprotected sex, and commercial sex work [3,4], as well as prevalent [5,6] and incident HIV infection [7-9]. Alcohol consumption has
also been associated with decreased access to HIV testing [10]. In addition, several studies of alcohol administration to macaques demonstrated increased SIV disease
progression [11]; however, observational studies of heavy
alcohol consumption and HIV disease progression in
humans have yielded mixed results [12-14]. Finally, alcohol consumption is consistently associated with decreased
antiretroviral therapy (ART) adherence in western countries [15], and increasingly in SSA [16-23], and heavy alcohol consumption has been associated with decreased
retention in care [24].
We recently found that self-reported alcohol consumption by persons with HIV decreased concurrently
with ART initiation in rural Uganda; almost two-thirds
(64%) of drinkers at baseline reported becoming and
remaining abstinent for the duration of follow-up, for a
median of 3.25 years [25]. Most became abstinent within
three months of starting ART, suggesting that ART initiation may be an important time to intervene to reduce
alcohol consumption. Reductions in alcohol use among
women in a multicenter HIV cohort study in the United
States have also been reported [26]. However, changes in
alcohol use earlier in the course of HIV care, that is,
after HIV counseling and testing (HCT), have not been
examined. Because alcohol appears to play an important
role in HIV transmission, reducing alcohol consumption
early in the course of HIV could have an important impact on the HIV epidemic. HCT provides a point of
health care contact that might be an opportune time to
intervene on heavy alcohol consumption [27]. Current
standard HCT guidelines, e.g. those published by the
United States Centers for Disease Control and Prevention [28], recommend addressing the use of alcohol or
drugs before sexual activity, but alcohol use itself is not
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directly addressed. Declines in sexual risk behavior due
to HCT have been demonstrated [29], and it is plausible
that other general health improvements might additionally occur after HCT.
For the above reasons, we sought to examine changes
in alcohol use in the year following HCT. We utilized
data collected in a randomized controlled trial of HCT
methods and enhanced linkage to HIV care at Mulago
Hospital in Kampala, Uganda [30] to examine whether
alcohol use declined in the year following HCT. We examined whether changes in alcohol consumption differed by HIV status and sex, and examined demographic
and other factors as predictors of hazardous and nonhazardous drinking following HCT. Among those with
HIV, we examined whether CD4 cell count at baseline
and initiation of ART were associated with declines in
drinking after HCT.

Methods
This study is an analysis of data collected as part of a
randomized controlled trial comparing an abbreviated
method of HCT to traditional full length HCT, and,
among those with HIV, comparing an enhanced protocol
for linkage to HIV care to standard linkage to care.
Study details, including a detailed flow diagram, have
been presented elsewhere [30].
Study population

Participants were recruited from May 2008 to June 2011
from inpatient medical wards and outpatient clinics (including emergency and casualty wards, medical outpatient clinics, and sexually transmitted disease clinics)
at Mulago Hospital in Kampala, Uganda. Eligibility criteria included being ≥18 years old, residing within
25 km of Mulago Hospital with no plans of moving,
having never tested positive for HIV, having last tested
HIV-negative at least one year prior, and being willing to
receive an HIV test and engage in study procedures. All
participants provided informed consent prior to study
participation and the study was approved by the institutional review boards of Makerere University, Uganda
National Council for Science and Technology, University
of California Los Angeles, and University of California
San Francisco.
Study visits and procedures

All participants completed a 30-minute, intervieweradministered survey at baseline. Participants were then
randomly assigned (1:1) to receive either traditional
HCT (45 minutes), or an abbreviated (15 minutes) version of HCT. Following HCT and determination of HIV
status, participants were randomized a second time. To
retain a roughly equivalent number of HIV-positive and
HIV-negative participants followed for one year, HIV-
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negative participants were randomized to follow-up or
no follow-up (roughly 1:1). HIV-positive participants were
randomized to receive enhanced or standard linkage to
HIV care (1:1); all were followed for one year. Follow-up
study interviews were conducted quarterly for one year,
and included assessment of HIV care and ART status, alcohol consumption, and sexual behaviors within the past
three months.
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Laboratory testing

HIV testing was conducted using a serial testing procedure using rapid antibody tests as described previously
[34]. HIV testing was conducted at Mulago Hospital;
CD4 cell count testing for those with HIV infection was
conducted at the Makerere University-Johns Hopkins
University laboratory.
Statistical analysis

Dependent variables

Alcohol use prior to baseline was examined using four categories: lifetime abstainer, past drinker (drank >3 months
prior), current (prior three months) non-hazardous
drinker, and current (prior three months) hazardous
drinker. We defined hazardous drinking using the Alcohol Use Disorders Identification Test – Consumption
(AUDIT-C) [31] with a cut-off of ≥3 for women and ≥4
for men; non-hazardous drinking was defined as any
current drinking that did not reach the AUDIT-C cut-off.
Following HCT, drinking in the prior three months among
those reporting current drinking at baseline was examined
as: none, non-hazardous drinking and hazardous drinking,
as defined above.
Covariates

Covariates of interest included demographics: participant sex, age, marital status, education, occupation, and
religion. We created a household wealth index to group
households based on ownership of durable goods, housing quality, and energy sources [32]. This variable was
divided into three categories: low (0-40%), middle (4180%), and high (81-100%) household wealth. We asked
about frequency of household hunger: sometimes/often
(>2 times/month), seldom (1–2 times/month), or never.
We included site of recruitment (inpatient ward, outpatient clinic, or emergency/casualty ward) as a potential
proxy for participant health. We examined social support using the Oslo Social Support scale [33], and categorized participants as having poor (score of 3–8),
moderate (9–11), or strong (12–14) social support. We
also examined whether any household members consumed alcohol in the past three months. Reason(s) for
HIV testing were also examined; while the questionnaire
allowed a participant to endorse more than one reason,
we created a hierarchical variable from these reasons: (a)
concerned about health/symptoms, (b) wanted to plan
for the future or just wanted to know one’s status, and
(c) other reasons. Among those with HIV, ART status
was ascertained using a list of medications at each
follow-up interview. We also included HCT study arm
(traditional or abbreviated) and, among those with HIV,
linkage to HIV care study arm (enhanced or standard),
in the analyses of alcohol use in the year following HCT.

We calculated frequency distributions for categorical
variables, and medians and interquartile ranges (IQR)
for continuous variables. We conducted unadjusted and
adjusted multinomial logistic regression analyses for the
baseline outcomes (lifetime abstainer, past drinker,
current non-hazardous drinker, and current hazardous
drinker). Among those who were current drinkers at
baseline, we also conducted unadjusted and adjusted
multinomial logistic regression analyses of alcohol use in
the one year following HCT, clustering on the participant to account for the repeated measures over time.
We included the study arms (HCT arm and, among
those with HIV, HIV linkage to care arm) as covariates
only in the analyses of alcohol use in the year following
HCT, as study randomization occurred after the baseline
interview. The levels of the outcome variable were: no
alcohol use in the past three months, current nonhazardous use, and current hazardous use. For each of
these models, we used a purposeful selection technique
[35] to create multivariable models. Covariates were initially included if they were associated in bivariate models
with a p-value ≤ 0.25; they were then excluded in a backwards stepwise fashion, keeping variables in the model if
they were associated at p ≤ 0.10. Next, any covariates
initially excluded based on the cut-off of p ≤ 0.25
were included one by one, and their significance was
re-assessed. They were retained in the final model if
p ≤ 0.10.
Next, to determine whether the time trends varied by
HIV status or sex in our model of alcohol consumption
following HCT, we conducted tests of interaction of
those two variables with time in the multivariable
models, one at a time, while adjusting for the other variables in the model [36]. As there was a significant interaction with HIV status and time (p = 0.02), and because
we were interested in examining variables relevant only
to HIV-positive participants, we also fit a multivariable
model among only the participants with HIV, using the
purposeful selection methods described above, and additionally allowing baseline CD4 cell count, linkage to
care study arm, and ART use to enter the model.
Data were missing at baseline and follow-up (15% of
observations had at least one missing value; 13% of
follow-up study visits were missing), so we conducted
multiple imputation using chained equations. The results
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using the imputed data were similar to the results using
listwise deletion; therefore we present the results using the
imputed data for the regression analyses.

Results
Participant characteristics

3389 participants were enrolled in the main study; HIV
prevalence was 30% (n = 1003). 1323 HIV negatives were
randomized to no follow-up, and 10 participants were
missing data on baseline alcohol use; therefore 2056 participants were included in the baseline analysis. More
than half of the participants (57%) were female (Table 1),
median age was 30 years (IQR: 25–38), and approximately half (49%) had more than a primary education.
Approximately one-third (32%) of participants were
Catholic, 31% were Protestant, 19% were Moslem, and
18% were Saved, Pentecostal, or another religion. Eighteen percent (18%) of participants reported having at
least one household member who had consumed alcohol
in the past three months. Most participants reported
that their household never went hungry (76%) and that
they had moderate or strong social support (81%). The
median CD4 cell count among those who were infected
with HIV was 285 cells/mm3 (IQR: 132–463).
Baseline alcohol use

Approximately 56% of the sample had ever consumed
any alcohol. Of the 1154 participants who reported ever
taking alcohol, 607 (53%) reported taking alcohol in the
prior three months. Among former drinkers, alcohol was
last consumed 3–12 months ago for 215 participants
(39%). Among current (prior three months) drinkers, 40%
of men and 30% of women reported hazardous alcohol
use, as defined by the AUDIT-C.
Table 2 shows the results from multinomial logistic regression of past, current non-hazardous, and current
hazardous alcohol use compared to lifetime abstention.
Independent correlates (p < 0.05) of past alcohol use versus lifetime abstention were: age (>35 years), religion
(Protestants more likely than Moslems), marital status
(previously married more likely than currently married),
household hunger (never hungry less likely than sometimes/often hungry), any alcohol use by household members, and HIV status (positive). Independent correlates
of current, non-hazardous alcohol use versus lifetime abstention were: sex (male), age (26–35 years), religion
(Catholics more likely than Protestants; Moslems and
Saved/Pentecostal/others less likely than Protestants),
household wealth (medium household wealth more
likely than low), and any alcohol use by household members. Lastly, independent predictors of current, hazardous
alcohol consumption compared to lifetime abstention
were: sex (male), age (older), religion (Moslems and
Saved/Pentecostal/others less likely than Protestants),

Page 4 of 14

social support (strong support more likely than moderate
support), any alcohol use by household members, recruitment at an outpatient clinic (versus an inpatient ward),
and HIV status (positive). The relative risk ratios (RRR) increased in size across the categories from past drinking, to
current non-hazardous drinking, to current hazardous
drinking for sex, age, and having a household member
who consumes alcohol.
Alcohol use in the year following HCT

Among current drinkers at baseline, both hazardous and
non-hazardous alcohol consumption decreased dramatically in the first three months after HCT for those with
and without HIV infection (Figure 1). Loss to follow-up
between hazardous and non-hazardous drinkers at baseline was similar; overall, 8% of hazardous drinkers and
8% of non-hazardous drinkers had no follow-up interviews. Study interview completion at 3, 6, 9, and
12 months was 89%, 85%, 86% and 86% respectively, for
those categorized as non-hazardous drinkers at baseline,
and 89%, 86%, 84% and 85% respectively, for those categorized as hazardous drinkers at baseline.
Among current drinkers at baseline, independent predictors (p < 0.05) of current, non-hazardous drinking
compared to no drinking in the year following HCT
were: sex (male), hazardous alcohol use at baseline, and
HIV status (negative) (Table 3). These variables were also
independent predictors of current, hazardous drinking
compared to no drinking, in addition to follow-up
month (less hazardous drinking at 9 months). HCT
study arm was not associated with non-hazardous or
hazardous drinking during follow-up.
In multivariable regression limited to current drinkers
at baseline with HIV (Table 4), independent predictors
of current, non-hazardous alcohol use after HCT were:
sex (male) and ART status (on ART more likely to not
drink). Independent predictors of current, hazardous alcohol consumption after HCT among those with HIV
were: hazardous alcohol use at baseline, and recruitment
at an emergency/casualty ward (less hazardous drinking
compared to those recruited at an inpatient ward). Linkage to care and HCT study arms were not associated
with non-hazardous or hazardous drinking during
follow-up.

Discussion
In a large sample of persons receiving HCT in Uganda,
almost one-third reported current alcohol use, and onethird of those met criteria for hazardous alcohol consumption. Among current drinkers, both hazardous and
non-hazardous drinking declined dramatically in the first
three months after HCT, and the decline was more dramatic among those with HIV. In the year following
HCT, continued drinking at both hazardous and non-
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Table 1 Baseline demographic and behavioral characteristics of participants undergoing HCT in Kampala, Uganda
Drinking status at baseline
Overall
(n = 2056)

Lifetime
abstainers
(n = 902)

Past
drinkers
(n = 547)

Current*,
non-hazardous drinkers
(prior 3 months)
(n = 352)

Current*,
hazardous drinkers
(prior 3 months)
(n = 189)

n (%)

n (%)

n (%)

n (%)

n (%)

Male

879 (42.8)

351 (38.9)

222 (40.6)

165 (46.9)

108 (57.1)

Female

1177 (57.3)

551 (61.1)

325 (59.4)

187 (53.1)

81 (42.9)

Gender

Age (overall median: 30; IQR: 25–38)
18–25

580 (28.2)

321 (35.6)

130 (23.8)

86 (24.4)

26 (13.8)

26–35

852 (41.4)

353 (39.1)

212 (38.8)

162 (46.0)

94 (49.7)

>35

624 (30.4)

228 (25.3)

205 (37.5)

104 (29.6)

69 (36.5)

Primary education or less

1043 (50.8)

439 (48.7)

278 (50.9)

191 (54.3)

102 (54.0)

More than primary education

1011 (49.2)

462 (51.3)

268 (49.1)

161 (45.7)

87 (46.0)

668 (32.5)

285 (31.6)

186 (34.0)

119 (33.8)

54 (28.6)

Education

Occupation
Laborer
Business/Sales/Technical

901 (43.8)

388 (43.1)

240 (43.9)

151 (42.9)

91 (48.2)

Other

486 (23.7)

228 (25.3)

121 (22.1)

82 (23.3)

44 (23.3)

Protestant

629 (30.6)

217 (24.1)

161 (29.4)

135 (38.4)

88 (46.6)

Religion

Catholic

651 (31.7)

198 (22.0)

176 (32.2)

169 (48.0)

76 (40.2)

Moslem

398 (19.4)

283 (31.4)

64 (11.7)

30 (8.5)

17 (9.0)

Saved/Pentecostal/Other

378 (18.4)

204 (22.6)

146 (26.7)

18 (5.1)

8 (4.2)

Marital status
Married

866 (42.1)

370 (41.0)

212 (38.8)

159 (45.2)

92 (48.7)

Married in the past

656 (31.9)

248 (27.5)

208 (38.1)

116 (33.0)

65 (34.4)

Never married

533 (25.9)

284 (31.5)

126 (23.1)

77 (21.9)

32 (16.9)

Household wealth
Low

921 (45.0)

411 (45.7)

246 (45.2)

144 (40.9)

96 (50.8)

Medium

807 (39.4)

346 (38.4)

207 (38.1)

155 (44.0)

72 (38.1)

High

321 (15.7)

143 (15.9)

91 (16.7)

53 (15.1)

21 (11.1)

Sometimes/Often
(>2 times/month)

295 (14.6)

103 (11.6)

108 (20.1)

30 (8.6)

34 (18.7)

How often do household
members go hungry?

Seldom (1–2 times/month)

200 (9.9)

66 (7.5)

61 (11.4)

39 (11.2)

28 (15.4)

Never

1522 (75.5)

717 (80.9)

368 (68.5)

280 (80.2)

120 (65.9)

Strong support

274 (13.9)

107 (12.2)

81 (15.8)

36 (10.4)

35 (19.7)

Moderate support

1311 (66.7)

628 (71.9)

325 (63.4)

254 (73.6)

86 (48.3)

Poor support

380 (19.3)

139 (15.9)

107 (20.9)

55 (15.9)

57 (32.0)

Inpatient wards

400 (19.5)

181 (20.1)

106 (19.4)

72 (20.5)

33 (17.5)

Outpatient clinics

1395 (67.9)

608 (67.4)

378 (69.1)

222 (63.1)

138 (73.0)

Emergency/casualty wards

261 (12.7)

113 (12.5)

63 (11.5)

58 (16.5)

18 (9.5)

Social support

Recruitment site
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Table 1 Baseline demographic and behavioral characteristics of participants undergoing HCT in Kampala, Uganda
(Continued)
Reasons for HIV testing
(illness > planning > other)
AIDS symptoms/concern
about current illness

652 (31.7)

241 (26.7)

201 (36.8)

117 (33.2)

70 (37.0)

Just wanted to know/plan
for future

1312 (63.8)

624 (69.2)

320 (58.5)

225 (63.9)

105 (55.6)

92 (4.5)

37 (4.1)

26 (4.8)

10 (2.8)

14 (7.4)

None

1671 (82.0)

805 (89.4)

439 (81.5)

276 (79.5)

108 (57.8)

Any

367 (18.0)

95 (10.6)

100 (15.6)

71 (20.5)

79 (42.3)

Never

902 (43.9)

902 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

Other
Any household members consumed
alcohol, past 3 months

Last time consumed alcohol

>5 years ago

191 (9.3)

0 (0.0)

191 (34.9)

0 (0.0)

0 (0.0)

1–5 years ago

141 (6.9)

0 (0.0)

141 (25.8)

0 (0.0)

0 (0.0)

3 months – 1 year ago

215 (10.5)

0 (0.0)

215 (39.3)

0 (0.0)

0 (0.0)

Prior 3 months

607 (29.5)

0 (0.0)

0 (0.0)

352 (100.0)

189 (100.0)

AUDIT-C at baseline (median (IQR))

0 (0–1)

HIV status
HIV Negative

1058 (51.5)

529 (58.7)

250 (45.7)

176 (50.0)

71 (37.6)

HIV Positive

998 (48.5)

373 (41.4)

297 (54.3)

176 (50.0)

118 (62.4)

Baseline CD4 cell count among
those with HIV (cells/mm3)
(overall median: 285; IQR: 132–463)
<200

359 (36.1)

139 (37.3)

122 (41.4)

53 (30.1)

35 (29.9)

200–349

233 (23.4)

85 (22.8)

66 (22.4)

44 (25.0)

29 (24.8)

350–499

202 (20.3)

74 (19.8)

60 (20.3)

34 (19.3)

26 (22.2)

> = 500

200 (20.1)

75 (20.1)

47 (15.9)

45 (25.6)

27 (23.1)

*n = 66 current drinkers were unable to be classified as hazardous or non-hazardous drinkers.

hazardous levels, as compared to abstinence, was more
likely among men, and those who were not infected with
HIV. Among those with HIV, current non-hazardous
drinking was less likely among those on ART.
Our findings on lifetime and current alcohol consumption are consistent with those of prior studies of alcohol
use in SSA. Alcohol use has previously been reported to
be less common among women in Uganda [1], and alcohol use is prohibited in the Moslem and Evangelical religions. Persons with HIV in our study were more likely
to have ever consumed alcohol (HIV status was associated with past and current hazardous use), which is consistent with the increasing evidence of a link between
alcohol consumption and HIV infection [6]. We additionally found that household alcohol use was associated with current hazardous and non-hazardous alcohol
use at baseline, with increased risk for hazardous use.
This suggests that peer norms play a role in alcohol consumption, as has been shown among adolescents and

college students [37]. In a previous study conducted in
Uganda, less loneliness and higher levels of social interactions were associated with an increased frequency of
alcohol use, suggesting that alcohol consumption is socially normative [38].
The decline in self-reported alcohol consumption during follow-up is consistent with our previous finding of
high levels of self-reported abstinence just prior to and
immediately following the start of ART in a cohort of persons initiating ART in rural southwest Uganda [25]. The
current findings extend the literature by examining a key
period in the time course of HIV infection, that is, prior to
HCT and in the year immediately following HCT. Selfreported alcohol consumption declined most dramatically
in the first three months following HCT, and additional
declines occurred among those with HIV, at least among
non-hazardous drinkers, when ART was initiated.
There are several plausible explanations for the decreases
in alcohol consumption. First, alcohol consumption may
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Table 2 Multinomial logistic regression of past, current non-hazardous, and current hazardous drinking status at
baseline compared to lifetime abstaining
Past drinking
RRR (95% CI)
Bivariable

Current, non-hazardous drinking
RRR (95% CI)

Multivariable

Bivariable

Multivariable

Current, hazardous drinking
RRR (95% CI)
Bivariable

Multivariable

Gender
Female

1.00

1.00

1.00

1.00

1.00

1.00

Male

1.07 (0.86, 1.33)

1.25 (0.98, 1.60)

1.40 (1.10, 1.77)

1.57 (1.19, 2.07)

2.10 (1.52, 2.89)

2.86 (1.96, 4.16)

18–25

1.00

1.00

1.00

1.00

1.00

1.00

26–35

1.48 (1.14, 1.93)

1.28 (0.95, 1.73)

1.69 (1.27, 2.25)

1.42 (1.01, 1.99)

3.23 (2.05, 5.08)

2.62 (1.53, 4.50)

>35

2.22 (1.68, 2.93)

1.94 (1.39, 2.71)

1.66 (1.21, 2.27)

1.33 (0.89, 1.98)

3.62 (2.25, 5.84)

2.83 (1.55, 5.18)

1.00

-

1.00

-

1.00

-

Age (years)

Education
Primary education or less
More than primary
education

0.92 (0.74, 1.13)

0.82 (0.65, 1.05)

0.81 (0.59, 1.12)

Occupation
Laborer

1.00

-

1.00

-

1.00

Business/sales/technical

0.95 (0.74, 1.21)

0.93 (0.71, 1.22)

1.24 (0.86, 1.79)

Other

0.81 (0.61, 1.08)

0.81 (0.59, 1.12)

1.01 (0.65, 1.55)

-

Religion
Protestant

1.00

1.00

1.00

1.00

1.00

1.00

Catholic

1.20 (0.90, 1.60)

1.19 (0.88, 1.60)

1.39 (1.04, 1.85)

1.35 (1.01, 1.81)

0.92 (0.64, 1.32)

0.84 (0.57, 1.24)

Moslem

0.30 (0.22, 0.43)

0.32 (0.23, 0.45)

0.16 (0.11, 0.25)

0.17 (0.11, 0.26)

0.14 (0.08, 0.24)

0.16 (0.09, 0.30)

Saved/Pentecostal/Other

0.96 (0.72, 1.29)

1.08 (0.79, 1.47)

0.14 (0.08, 0.23)

0.15 (0.09, 0.24)

0.09 (0.04, 0.19)

0.12 (0.05, 0.25)

Marital status
1.00

1.00

1.00

1.00

1.00

1.00

Previously married

Married

1.47 (1.14, 1.88)

1.44 (1.09, 1.90)

1.05 (0.80, 1.39)

1.19 (0.87, 1.64)

1.05 (0.73, 1.49)

1.51 (1.00, 2.28)

Never married

0.77 (0.59, 1.01)

0.98 (0.72, 1.35)

0.63 (0.47, 0.85)

0.72 (0.50, 1.04)

0.44 (0.28, 0.68)

0.83 (0.48, 1.44)

Household assets
1.00

1.00

1.00

1.00

1.00

1.00

Medium

Low

1.00 (0.79, 1.26)

1.18 (0.91, 1.52)

1.30 (1.01, 1.69)

1.48 (1.11, 1.96)

0.89 (0.64, 1.24)

1.22 (0.84, 1.78)

High

1.06 (0.78, 1.44)

1.21 (0.87, 1.68)

1.13 (0.80, 1.61)

1.31 (0.89, 1.91)

0.64 (0.39, 1.07)

0.75 (0.43, 1.29)

1.00

1.00

1.00

1.00

1.00

1.00

How often do household members
go hungry?
Sometimes/Often
(>2 times/month)
Seldom (1–2 times/month)

0.90 (0.58, 1.39)

0.82 (0.52, 1.31)

1.48 (0.88, 2.50)

1.32 (0.75, 2.29)

1.19 (0.66, 2.12)

1.32 (0.68, 2.54)

Never

0.49 (0.36, 0.66)

0.59 (0.42, 0.82)

1.00 (0.68, 1.46)

1.13 (0.75, 1.70)

0.45 (0.30, 0.69)

0.80 (0.49, 1.32)

1.00

1.00

1.00

1.00

1.00

1.00

Social support
Strong support
Moderate support

0.69 (0.50, 0.95)

0.73 (0.52, 1.02)

0.97 (0.67, 1.40)

1.04 (0.70, 1.54)

0.40 (0.26, 0.62)

0.52 (0.32, 0.84)

Poor support

1.03 (0.70, 1.52)

0.96 (0.64, 1.46)

1.14 (0.72, 1.82)

1.37 (0.84, 2.24)

1.27 (0.78, 2.06)

1.49 (0.84, 2.63)

1.00

1.00

1.00

1.00

1.00

1.00

1.92 (1.42, 2.60)

1.80 (1.29, 2.50)

2.32 (1.68, 3.21)

1.95 (1.36, 2.79)

6.24 (4.33, 8.99)

5.74 (3.80, 8.67)

Any household members consumed
alcohol, past 3 months
None
Any
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Table 2 Multinomial logistic regression of past, current non-hazardous, and current hazardous drinking status at
baseline compared to lifetime abstaining (Continued)
Recruitment site
1.00

1.00

1.00

1.00

1.00

1.00

Outpatient clinics

Inpatient wards

1.06 (0.81, 1.39)

1.09 (0.81, 1.46)

1.00 (0.74, 1.36)

1.07 (0.77, 1.48)

1.25 (0.83, 1.89)

1.63 (1.03, 2.57)

Emergency/casualty wards

0.95 (0.64, 1.41)

0.84 (0.56, 1.26)

1.35 (0.90, 2.03)

1.34 (0.87, 2.08)

0.88 (0.47, 1.62)

1.01 (0.52, 1.98)

1.00

-

1.00

-

1.00

-

Reasons for HIV testing
Just wanted to know/plan
for future
AIDS symptoms/concern
about current illness

1.63 (1.29, 2.05)

1.39 (1.08, 1.80)

1.67 (1.20, 2.34)

Other

1.37 (0.82, 2.30)

0.92 (0.48, 1.75)

2.25 (1.18, 4.30)

HIV status
HIV negative

1.00

1.00

1.00

1.00

1.00

1.00

HIV positive

1.68 (1.36, 2.09)

1.49 (1.17, 1.88)

1.42 (1.12, 1.80)

1.15 (0.88, 1.51)

2.34 (1.70, 3.22)

1.88 (1.30, 2.73)

RRR: Relative risk ratio.
CI: Confidence interval.

have declined as a result of the precipitating factors that
led the participants to seek health care services at Mulago
Hospital. In our previous study, those with lower health
scores were more likely to become abstinent [25], and
health conditions have been previously cited as a reason
for attempts to reduce or abstain from alcohol use
[39-41]. Those seeking health care may represent a select
group, i.e. they may be those who are currently ready and
willing to engage in health-preserving behavior in general,
or may be those who are too ill to drink. Perhaps the
health condition serves as a “learnable moment”, in which
the patient recognizes a link between their health and
drinking, which spurs reductions in drinking independent
of any intervention [42]. In addition, contact with health
care providers may be an intervention in itself. In a study
of patients in residential drug and alcohol detoxification
programs, receipt of primary care was associated with a
significant decrease in alcohol use severity [43]. The counseling included during the HCT provided by this study
may also have been an intervention, although neither of
the two counseling protocols (traditional or abbreviated)
explicitly addressed alcohol use. However, there were no

differences in alcohol use after HCT by method of counseling, suggesting no effect of HCT counseling. The majority (80%) of those who were infected with HIV received
follow-up care [30], and the ISS clinic at Mulago Hospital
discourages all alcohol consumption, especially at ART
initiation. In addition, men who consume more than 14
drinks per week and women who consume more than 11
drinks per week, and lighter drinkers who do not quit
drinking, are referred to a psychiatrist for counseling. This
may explain the greater decrease in drinking among those
with HIV, and especially among patients on ART. ART
initiation may have a variety of health benefits beyond the
direct effects on HIV disease. It has been found to be associated with other positive health outcomes, such as reduced internalized stigma [44], increased food security,
nutritional status, physical health status [45], and decreased depression status [46]. If alcohol consumption declined for the reasons noted above, then these findings
suggest that hospital and clinic entry, HCT, and for those
infected with HIV, ART initiation, may be opportune
times to intervene on alcohol use, and future interventions
should capitalize on these opportunities. Just as emergency

Figure 1 Hazardous and non-hazardous drinking at study visits following HIV counseling and testing (HCT), among current drinkers at
baseline, by HIV status. 1a. 294 HIV infected drinkers. 1b. 247 HIV negative drinkers.
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Table 3 Multinomial logistic regression of non-hazardous and hazardous drinking compared to no current drinking in
the year following HCT, among baseline drinkers
Non-hazardous drinking RRR (95% CI)
Bivariable

Multivariable

Hazardous drinking RRR (95% CI)
Bivariable

Multivariable

Gender
Female

1.00

1.00

1.00

1.00

Male

1.95 (1.50, 2.53)

1.81 (1.39, 2.35)

2.07 (1.43, 2.99)

1.83 (1.26, 2.65)

18–25

1.00

-

1.00

-

Age (years)

26–35

0.94 (0.67, 1.32)

0.94 (0.59, 1.51)

>35

1.15 (0.80, 1.66)

1.11 (0.67, 1.84)

Education
Primary education or less
More than primary education

1.00

-

0.97 (0.75, 1.26)

1.00

-

1.37 (0.95, 1.95)

Occupation
Laborer

1.00

-

1.00

Business/sales/technical

0.91 (0.68, 1.22)

1.37 (0.89, 2.10)

Other

0.94 (0.66, 1.33)

1.32 (0.78, 2.25)

-

Religion
Protestant

1.00

-

1.00

Catholic

0.96 (0.73, 1.27)

1.00 (0.68, 1.47)

Moslem

0.84 (0.52, 1.38)

0.89 (0.46, 1.74)

Saved/Pentecostal/Other

0.58 (0.28, 1.21)

0.82 (0.36, 1.90)

-

Marital status
Married

1.00

-

1.00

Previously married

0.69 (0.51, 0.92)

0.69 (0.45, 1.04)

Never married

0.84 (0.59, 1.20)

1.04 (0.65, 1.66)

-

Household assets
Low

1.00

-

1.00

Medium

0.92 (0.70, 1.22)

1.07 (0.73, 1.57)

High

1.09 (0.72, 1.65)

1.20 (0.68, 2.13)

-

How often do household members
go hungry?
Sometimes/Often (>2 times/month)

1.00

-

1.00

Seldom (1–2 times/month)

0.93 (0.56, 1.54)

1.24 (0.61, 2.50)

Never

0.97 (0.66, 1.41)

1.13 (0.66, 1.93)

-

Social support
Strong support

1.00

-

1.00

Moderate support

0.86 (0.60, 1.23)

0.89 (0.52, 1.52)

Poor support

0.96 (0.63, 1.48)

1.03 (0.56, 1.89)

-

Hazardous alcohol use at baseline?
No

1.00

1.00

1.00

1.00

Yes

1.60 (1.21, 2.12)

1.72 (1.29, 2.29)

2.40 (1.65, 3.51)

2.68 (1.81, 3.96)

1.00

-

1.00

-

Any household members consumed
alcohol, past 3 months
None
Any

1.22 (0.91, 1.64)

1.48 (1.01, 2.16)
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Table 3 Multinomial logistic regression of non-hazardous and hazardous drinking compared to no current drinking in
the year following HCT, among baseline drinkers (Continued)
Recruitment site
Inpatient wards

1.00

-

1.00

Outpatient clinics

1.02 (0.71, 1.46)

0.90 (0.56, 1.44)

Emergency/casualty wards

0.67 (0.41, 1.10)

0.41 (0.20, 0.83)

-

Reasons for HIV testing
Just wanted to know/plan for future

1.00

-

1.00

AIDS symptoms/concern about current illness

0.85 (0.64, 1.12)

0.88 (0.59, 1.32)

Other

1.06 (0.62, 1.82)

1.44 (0.64, 3.26)

-

HIV status
HIV negative

1.00

1.00

1.00

1.00

HIV positive

0.52 (0.40, 0.68)

0.49 (0.37, 0.65)

0.45 (0.31, 0.65)

0.40 (0.27, 0.58)

1.00

-

1.00

-

HCT arm
Abbreviated HCT
Traditional HCT

1.01 (0.77, 1.31)

0.86 (0.60, 1.23)

Follow-up month
3 months

1.00

1.00

1.00

1.00

6 months

1.06 (0.83, 1.34)

1.05 (0.82, 1.35)

0.81 (0.59, 1.10)

0.80 (0.58, 1.11)

9 months

1.08 (0.84, 1.39)

1.07 (0.83, 1.39)

0.63 (0.44, 0.90)

0.62 (0.43, 0.90)

12 months

0.80 (0.62, 1.04)

0.79 (0.60, 1.03)

0.74 (0.53, 1.03)

0.72 (0.51, 1.02)

RRR: Relative risk ratio.
CI: Confidence interval.

department visits for alcohol-related trauma provide a
“learnable moment” for alcohol reduction, HCT may also
provide such an opportunity.
However, it is also possible that the reductions in alcohol use are due to assessment reactivity. Assessment
reactivity occurs when the assessment of alcohol consumption itself increases self-awareness of alcohol
problems and thus triggers reductions in alcohol consumption [47]. A related explanation could be the
Hawthorne effect, in which those being studied change
their behavior. Either of these effects could explain the
trends towards decreasing alcohol consumption seen in
other prospective research studies, including a study in
women with HIV and a study of injecting drug users
in the United States [26,48]; however, they do not explain
why the decreases were greater in those with HIV versus
those without. Another reason for the decline in drinking
may be regression to the mean, whereby by selecting the
current drinkers at baseline, some revert to non-drinking
on subsequent visits. However, one would expect an equal
fraction of non-drinkers to become drinkers, and this was
not the case (only 13% of non-drinkers at baseline reported any drinking at follow-up).
Limitations

The most important limitation is that the measures of
drinking are self-reported, and under-report is a reasonable

concern. Socially desirable reporting of stigmatized behavior is a common problem in health care settings. Those
with HIV were likely to have been instructed to cease
drinking during their HIV clinic visits, and might fear that
ART may be denied if they report drinking [49]. We have
previously reported on the use of biomarkers to detect
under-reported alcohol use in Uganda [50,51]; however,
we were unable to collect biological markers to corroborate self-report in this study. Nonetheless, the correlates of
baseline and follow-up drinking were consistent with previous literature; for example, men drinking and Moslems
not drinking, which alleviates some of this concern. Another limitation is that the study was not designed to
examine alcohol consumption; therefore, we were unable
to explore psycho-social correlates of drinking after HCT.
An additional limitation is that we did not collect data on
drug use, and thus are unable to comment on any changes
in drug use that may have occurred following HCT. However, drug use in Uganda is uncommon; as reported by the
World Health Organisation, <1% of men and women in
Uganda in 2004 had a drug use disorder [52]. Similarly, in
a study of HIV-positive and HIV-negative female sex
workers in Kampala, a group one would suspect would
have high levels of drug use, only 8% reported ever using
marijuana or khat, and only 2 women (0.2%) had ever
injected heroin, while 78% of women reported alcohol use
[53]. Therefore, it is likely that very few of the participants
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Table 4 Multinomial logistic regression of non-hazardous and hazardous drinking compared to no current drinking in
the year following HCT, among HIV infected baseline drinkers
Current, non-hazardous drinking
RRR (95% CI)
Bivariable

Multivariable

Current, hazardous drinking
RRR (95% CI)
Bivariable

Multivariable

Gender
Female

1.00

1.00

1.00

1.00

Male

1.93 (1.32, 2.82)

1.92 (1.31, 2.82)

1.65 (0.96, 2.86)

1.42 (0.78, 2.56)

18–25

1.00

-

1.00

-

26–35

1.00 (0.62, 1.59)

0.76 (0.38, 1.55)

>35

1.21 (0.70, 2.08)

0.80 (0.35, 1.81)

Age (years)

Education
Primary education or less
More than primary
education

1.00

-

1.17 (0.81, 1.71)

1.00

-

1.25 (0.72, 2.16)

Occupation
Laborer

1.00

-

1.00

Business/sales/technical

0.72 (0.47, 1.10)

0.96 (0.53, 1.74)

Other

0.86 (0.51, 1.46)

1.14 (0.55, 2.35)

-

Religion
Protestant

1.00

-

1.00

Catholic

0.87 (0.58, 1.29)

0.83 (0.47, 1.45)

Moslem

0.66 (0.32, 1.34)

0.46 (0.15, 1.48)

Saved/Pentecostal/Other

0.49 (0.18, 1.37)

0.86 (0.24, 3.01)

-

Marital status
Married

1.00

-

1.00

Previously married

0.79 (0.53, 1.17)

0.92 (0.51, 1.64)

Never married

0.83 (0.46, 1.51)

1.51 (0.70, 3.24)

-

Household assets
Low

1.00

-

1.00

Medium

1.04 (0.69, 1.56)

1.20 (0.67, 2.15)

High

0.91 (0.50, 1.64)

1.60 (0.75, 3.43)

-

How often do household members
go hungry?
Sometimes/Often
(>2 times/month)

1.00

-

1.00

Seldom (1–2 times/month)

0.76 (0.39, 1.49)

1.00 (0.41, 2.46)

Never

0.81 (0.50, 1.32)

0.85 (0.43, 1.69)

-

Social support
Strong support

1.00

-

1.00

Moderate support

0.59 (0.36, 0.96)

0.58 (0.28, 1.19)

Poor support

0.69 (0.38, 1.25)

0.90 (0.41, 1.99)

-

Hazardous alcohol use at baseline?
No

1.00

1.00

1.00

1.00

Yes

1.49 (0.96, 2.31)

1.42 (0.91, 2.23)

3.21 (1.79, 5.75)

3.15 (1.74, 5.70)
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Table 4 Multinomial logistic regression of non-hazardous and hazardous drinking compared to no current drinking in
the year following HCT, among HIV infected baseline drinkers (Continued)
Any household members consumed
alcohol, past 3 months
None
Any

1.00

-

1.04 (0.68, 1.59)

1.00

-

1.52 (0.85, 2.72)

Recruitment site
1.00

1.00

1.00

1.00

Outpatient clinics

Inpatient wards

1.04 (0.62, 1.75)

1.09 (0.65, 1.83)

0.70 (0.34, 1.42)

0.65 (0.30, 1.41)

Emergency/casualty wards

0.52 (0.27, 1.01)

0.57 (0.29, 1.13)

0.24 (0.08, 0.72)

0.26 (0.08, 0.85)

1.00

-

1.00

-

Reasons for HIV testing
Just wanted to know/plan for future
AIDS symptoms/concern about
current illness

0.84 (0.57, 1.24)

1.40 (0.80, 2.46)

Other

1.50 (0.64, 3.49)

2.71 (0.93, 7.92)

HCT arm
Abbreviated HCT
Traditional HCT

1.00

-

0.96 (0.66, 1.41)

1.00

-

1.01 (0.59, 1.72)

Linkage to care arm
Enhanced linkage to care

1.00

Standard linkage to care

0.97 (0.67, 1.42)

-

1.00

-

0.98 (0.57, 1.67)

Follow-up month
3 months

1.00

1.00

1.00

1.00

6 months

0.83 (0.56, 1.21)

0.89 (0.60, 1.33)

0.65 (0.40, 1.08)

0.68 (0.40, 1.16)

9 months

1.27 (0.88, 1.84)

1.48 (1.00, 2.22)

0.75 (0.42, 1.36)

0.84 (0.45, 1.57)

12 months

0.69 (0.47, 1.01)

0.83 (0.54, 1.26)

0.78 (0.48, 1.26)

0.88 (0.52, 1.49)

1.00

-

1.00

-

Baseline CD4 count
<200
200–349

1.59 (0.94, 2.68)

1.15 (0.53, 2.47)

350–499

1.81 (1.03, 3.18)

1.50 (0.68, 3.28)

> = 500

1.60 (0.95, 2.71)

1.47 (0.68, 3.19)

Taking ART?
No

1.00

1.00

1.00

1.00

Yes

0.52 (0.36, 0.76)

0.50 (0.33, 0.76)

0.68 (0.38, 1.21)

0.61 (0.33, 1.13)

RRR: Relative risk ratio.
CI: Confidence interval.

were illicit drug users. Another limitation is that our results may not be generalizable to other populations in
SSA. For example, a study in South Africa of HIV-infected
patients on ART found a higher proportion of hazardous
drinking among ever drinkers (75% of men and 55% of
women, as defined using AUDIT cutoffs of ≥8 for men
and ≥6 for women) than was observed in our study [54].
A population-based study in Botswana, defining heavy
drinking as >14 drinks/week for women and >21 drinks/
week for men, also found a higher proportion of heavy
drinking (54% of men and 58% of women) than among
drinkers in our study [55]. Social controls may be stronger

in Uganda than some SSA countries; HIV patients in particular in Uganda may be more compliant to the advice
they receive from health care workers than patients in
other countries. Thus, our results should be interpreted
with caution when applied to other settings. Further study
of how alcohol consumption changes after HCT in other
countries in SSA would be valuable.

Conclusions
Despite these limitations, our findings significantly extend the previous literature of alcohol use in Uganda
and SSA, to examine patterns in self-reported alcohol
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consumption prior to and after HIV testing. The findings suggest that HIV testing and ART initiation may be
ideal venues for brief interventions. Screening and brief
intervention (SBI) have been found to be efficacious in
reducing alcohol consumption among those in primary
care [56]; however, it is unknown whether such findings
translate to resource-constrained settings [56]. Further
work is needed to determine whether such interventions
will be efficacious and whether they may be feasible to
implement in SSA.
Abbreviations
AUDIT-C: Alcohol Use Disorders Identification Test - Consumption;
ART: Antiretroviral therapy; CI: Confidence interval; HCT: HIV counseling and
testing; RRR: Relative risk ratio; SBI: Screening and brief intervention;
SSA: Sub-Saharan Africa.
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